Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Andrei Dan Radu"'
Autor:
Silvia DEACONU, Alexandru DEACONU, Alina SCARLATESCU, Ioana PETRE, Sebastian ONCIUL, Aura VIJIAC, Amalia PETRE, Gabriela MARASCU, Corneliu IORGULESCU, Andrei Dan RADU, Stefan BOGDAN, Radu VATASESCU, Maria DOROBANTU
Publikováno v:
Modern Medicine, Vol 28, Iss 2, Pp 153-159 (2021)
Background: Cardiac resynchronization therapy (CRT) is an established treatment for heart failure with reduced ejection fraction (HfrEF). Etiology may influence the outcome of patients undergoing CRT. Objective: to evaluate whether etiology (ischemic
Externí odkaz:
https://doaj.org/article/3966dfe8ea4b452aa074ba5cf7360e02
Autor:
Andrei Dan Radu, Alexandru Zlibut, Alina Scarlatescu, Cosmin Cojocaru, Stefan Bogdan, Alexandru Scafa-Udriște, Maria Dorobantu
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1156 (2023)
Cardiac resynchronization therapy (CRT) restores ventricular dyssynchrony, improving left ventricle (LV) systolic function, symptoms, and outcome in patients with heart failure, systolic dysfunction, and prolonged QRS interval. The left atrium (LA) p
Externí odkaz:
https://doaj.org/article/331805cf1026412f99aec6ac70154bd8
Autor:
Andrei Dan Radu, Cosmin Cojocaru, Sebastian Onciul, Alina Scarlatescu, Alexandru Zlibut, Alexandrina Nastasa, Maria Dorobantu
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 350 (2023)
Hypertrophic cardiomyopathy (HCM) is an inherited primary myocardial disease characterized by asymmetrical/symmetrical left ventricle (LV) hypertrophy, with or without LV outflow tract (LVOT) dynamic obstruction, and poor prognosis. Cardiac resynchro
Externí odkaz:
https://doaj.org/article/cbe932f9c8694676b49971d2716d5e31
Autor:
ANDREI DAN RADU-COSNITA, ALEXANDRU NESIU, PATRICIA LORENA BERZAVA, SIMONA CERBU, ANDREI COSMA, SERBAN COMSA, SIMONA SARB, ADELA MARIA FERICIAN, OVIDIU CATALIN FERICIAN, ANCA MARIA CIMPEAN
Publikováno v:
Anticancer Research. 42:1313-1325
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 2, Pp 311-317 (2021)
Acute myocardial infarction (AMI) causes severe metabolic and electrophysiological changes that induce silent or symptomatic life-threatening arrhythmias. Ventricular arrhythmias and atrial fibrillation are common during the early phase of AMI and ar
Autor:
Andrei Dan, Radu-Cosnita, Alexandru, Nesiu, Patricia Lorena, Berzava, Simona, Cerbu, Andrei, Cosma, Serban, Comsa, Simona, Sarb, Adela Maria, Ferician, Ovidiu Catalin, Ferician, Anca Maria, Cimpean
Publikováno v:
Anticancer research. 42(3)
Chloride intracellular channel protein 1 (CLIC1) is known as a promoter of cancer progression, metastasis, and angiogenesis. Thus, CLIC1 could be a future therapeutic target. This study aimed to evaluate the effect of anti-CLIC1 antibodies on tumour
Autor:
Alina Scarlatescu, Radu Vatasescu, Gabriela Marascu, Stefan Bogdan, A E Vijiiac, Silvia Deaconu, Sebastian Onciul, Ioana Petre, Alexandru Deaconu, D Zamfir, Corneliu Iorgulescu, Andrei Dan Radu
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 11
Journal of Clinical Medicine, Vol 10, Iss 2442, p 2442 (2021)
Volume 10
Issue 11
Journal of Clinical Medicine, Vol 10, Iss 2442, p 2442 (2021)
Background: We aimed to evaluate whether right ventricle (RV) longitudinal strain indexed to pulmonary arterial systolic pressure (PASP) has prognostic significance in patients undergoing cardiac resynchronization therapy (CRT). Methods: Patients und